Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Systemic Glucocorticoids in Moderate-Severe Bronchiolitis
NCT02571517Phase 4Completed
- Sponsor
- Fundació Sant Joan de Déu
- Start
- Nov 2011
- Primary completion
- Dec 2013
- Modality
- Orthosteric Ligands
01
Overview
Phase 4, randomised, double-blind trial of methylprednisolone injection and prednisolone in bronchiolitis (2 arms), sponsored by Fundació Sant Joan de Déu. Primary endpoints: Change from Baseline in inflammatory response at 1 week and Morbidity episodes at 14 months. Started Nov 2011; status: completed.
02
Drugs
methylprednisolone injectionprednisolone
03
Conditions
bronchiolitis
Beyond the preview
Go deeper on NCT02571517.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02571517.